The present study proposes a tumor-promoting role of CD8Low ST2L+ regulatory T lymphocytes via effects of CXCR4-enhancing S1P4 receptor signaling, which is in accordance with current concepts of anti-cancer immunotherapy. This evidence concerns the gene CXCR4 and neoplasm.